Matches in Wikidata for { <http://www.wikidata.org/entity/Q98906550> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q98906550 description "article scientifique publié en 2020" @default.
- Q98906550 description "articolo scientifico (pubblicato il 2020)" @default.
- Q98906550 description "artikull shkencor i botuar më 01 janar 2020" @default.
- Q98906550 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q98906550 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q98906550 description "scientific article published on 01 January 2020" @default.
- Q98906550 description "wetenschappelijk artikel" @default.
- Q98906550 description "наукова стаття, опублікована 1 січня 2020" @default.
- Q98906550 description "научна статия" @default.
- Q98906550 name "Pharmacokinetic Properties of Orally Administered 4'-Cyano-2'-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats" @default.
- Q98906550 name "Pharmacokinetic Properties of Orally Administered 4'-Cyano-2'-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats" @default.
- Q98906550 name "Pharmacokinetic Properties of Orally Administered 4'-Cyano-2'-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats" @default.
- Q98906550 type Item @default.
- Q98906550 label "Pharmacokinetic Properties of Orally Administered 4'-Cyano-2'-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats" @default.
- Q98906550 label "Pharmacokinetic Properties of Orally Administered 4'-Cyano-2'-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats" @default.
- Q98906550 label "Pharmacokinetic Properties of Orally Administered 4'-Cyano-2'-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats" @default.
- Q98906550 prefLabel "Pharmacokinetic Properties of Orally Administered 4'-Cyano-2'-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats" @default.
- Q98906550 prefLabel "Pharmacokinetic Properties of Orally Administered 4'-Cyano-2'-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats" @default.
- Q98906550 prefLabel "Pharmacokinetic Properties of Orally Administered 4'-Cyano-2'-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats" @default.
- Q98906550 P1433 Q98906550-4E415AA9-66E7-4D75-A153-38497A375B85 @default.
- Q98906550 P1476 Q98906550-A967DE47-666E-4721-8531-797CB5B297D1 @default.
- Q98906550 P2093 Q98906550-0F902FCD-FDFD-4E14-A927-2B4399CB2A10 @default.
- Q98906550 P2093 Q98906550-1D2806CC-C195-416C-BB71-27C41FF5EB4D @default.
- Q98906550 P2093 Q98906550-61464D8C-82B6-4A28-A0D2-C9F92C0DBF74 @default.
- Q98906550 P2093 Q98906550-7C1855C9-15E4-4C41-894A-1542D576B41F @default.
- Q98906550 P2093 Q98906550-8AD05AF8-A5FF-4E86-9349-C9B863FD049B @default.
- Q98906550 P2093 Q98906550-D295200C-7B30-4FE0-8BD4-5E2BFBC6F0E7 @default.
- Q98906550 P304 Q98906550-99B684D0-ABF7-4936-8678-1CF410DD9F2A @default.
- Q98906550 P31 Q98906550-BA17AFF0-F30D-46FF-ADBE-151D7F4F5823 @default.
- Q98906550 P356 Q98906550-C3C8C79F-DCC2-4174-8063-172643B09CAD @default.
- Q98906550 P433 Q98906550-0B28EB05-7B2A-4A2F-AD32-94519686D8ED @default.
- Q98906550 P478 Q98906550-DF28AEDB-0453-4091-A475-FF242B143AE6 @default.
- Q98906550 P577 Q98906550-4595D3D7-864C-4398-BFAF-97AD1818637E @default.
- Q98906550 P698 Q98906550-E8917E2D-7F19-4469-99DA-A8B6F92D643D @default.
- Q98906550 P921 Q98906550-4F2D9316-E0F6-451D-9E67-930C02C476F6 @default.
- Q98906550 P921 Q98906550-940C3063-F679-4D72-AACD-F67E576FA5F8 @default.
- Q98906550 P356 BPB.B20-00372 @default.
- Q98906550 P698 32879218 @default.
- Q98906550 P1433 Q15754240 @default.
- Q98906550 P1476 "Pharmacokinetic Properties of Orally Administered 4'-Cyano-2'-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats" @default.
- Q98906550 P2093 "Hiroaki Mitsuya" @default.
- Q98906550 P2093 "Kazuaki Taguchi" @default.
- Q98906550 P2093 "Keishi Yamasaki" @default.
- Q98906550 P2093 "Mai Hashimoto" @default.
- Q98906550 P2093 "Masaki Otagiri" @default.
- Q98906550 P2093 "Shuhei Imoto" @default.
- Q98906550 P304 "1426-1429" @default.
- Q98906550 P31 Q13442814 @default.
- Q98906550 P356 "10.1248/BPB.B20-00372" @default.
- Q98906550 P433 "9" @default.
- Q98906550 P478 "43" @default.
- Q98906550 P577 "2020-01-01T00:00:00Z" @default.
- Q98906550 P698 "32879218" @default.
- Q98906550 P921 Q323936 @default.
- Q98906550 P921 Q6844 @default.